CD274 and neoplasm: Moreover, these data suggest that anti-PD-L1-associated increases in TAM chemokines require de novo recruitment of circulating cells or the introduction of additional circulating factors, and cannot be mediated by cells already present in the tumour (i.e. ex vivo tumour preparations).